Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
General use-results survey of VTAMA in plaque psoriasis
jRCT2031250238Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tapinarof in plaque psoriasis, sponsored by Shionogi & Co., Ltd. Primary endpoints: Incidence of onset of adverse drug reactions, Local skin symptoms at application site and 1 more. Started Jul 2025; status: recruiting.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2031250238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250238.